Tapani Liukkonen - Concepedia

Author

Tapani Liukkonen

Moisio Hospital

Also Known As

T Liukkonen, T. J. O. Liukkonen, T. Liukkonen, TAPANI LIUKKONEN, Tapani J. O. Liukkonen, Tapani Liukkonen

Publications

Citations

H-Index

Concepts

All Affiliations

Moisio Hospital Hyvinkää Hospital Turku University Hospital Tampere University Hospital

About

Tapani Liukkonen is an author at Moisio Hospital specializing in medicine, oncology, and urology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	12	12	757
2	Health Sciences	1	1	158
3	Public Health	1	1	67
4	Cell Biology	1	1	40
5	Emergency Medicine	1	1	158

Tapani Liukkonen

Publications

987

Citations

H-Index

Page 1

	Year	Citations
Epidemiology and traumatology of injuries in elite soccer: a prospective study in Finland Peter Lüthje, Ilona Nurmi, Matti Kataja, Scandinavian Journal of Medicine and Science in Sports TraumatologySurgeryInjury PreventionElite SoccerKnee Injury	1996	158
Factors Explaining Recurrence in Patients Undergoing Chemoimmunotherapy Regimens for Frequently Recurring Superficial Bladder Carcinoma Eero Kaasinen, Erkki Rintala, Jouko Viitanen, European Urology UrologyGenitourinary CancerMedicineCancer RecurrenceImmune Checkpoint Inhibitor	2002	154
Prognostic Value of MIB-1 Score, p53, EGFr, Mitotic Index and Papillary Status in Primary Superficial (Stage pTa/T1) Bladder Cancer: A Prospective Comparative Study Tapani Liukkonen, Pertti Rajala, Mika Raitanen, European Urology UrologyPerineural InvasionUrologic Cancer EpidemiologyGenitourinary CancerMedicine	1999	98
Perioperative single dose instillation of epirubicin or interferon-alpha after transurethral resection for the prophylaxis of primary superficial bladder cancer recurrence: a prospective randomized multicenter study--FinnBladder III long-term results. Pertti Rajala, Eero Kaasinen, Mika Raitanen, PubMed	2002	82
Perioperative Single Dose Instillation of Epirubicin or Interferon-α After Transurethral Resection for The Prophylaxis of Primary Superficial Bladder Cancer Recurrence: A Prospective Randomized Multicenter Study—Finnbladder III Long-Term Results Pertti Rajala, Eero Kaasinen, Mika Raitanen, The Journal of Urology Urogenital RadiologyUrological ResearchUrologySurgical OncologyUrologic Cancer Epidemiology	2002	67
TRANSURETHRAL RESECTION WITH PERIOPERATIVE INSTILLATION OF INTERFERON-alpha OR EPIRUBICIN FOR THE PROPHYLAXIS OF RECURRENT PRIMARY SUPERFICIAL BLADDER CANCER: A PROSPECTIVE RANDOMIZED MULTICENTER STUDY-FINNBLADDER III Pertti Rajala, Tapani Liukkonen, Mika Raitanen, The Journal of Urology	1999	54
Evaluation of p21 WAF1/CIP1 and cyclin D 1 expression in the progression of superficial bladder cancer Tapani Liukkonen, P. Lipponen, Mika Raitanen, Urological Research UrologyOncologyGenitourinary CancerSuperficial Bladder CancerD 1	2000	44
Analysis of false-positive BTA stat test results in patients followed up for bladder cancer Mika Raitanen, Eero Kaasinen, O Lukkarinen, Urology Urological ResearchUrologyUrologic Cancer EpidemiologyGenitourinary CancerMedicine	2001	42
Reduced expression of retinoblastoma (Rb) gene protein is related to cell proliferation and prognosis in transitional-cell bladder cancer P. Lipponen, Tapani Liukkonen Journal of Cancer Research and Clinical Oncology Tumor BiologyUrologyCell RegulationGenitourinary CancerTransitional-cell Bladder Cancer	1995	40
Long-term Outcome of Patients with Frequently Recurrent Non–muscle-invasive Bladder Carcinoma Treated with One Perioperative Plus Four Weekly Instillations of Mitomycin C Followed by Monthly Bacillus Calmette-Guérin (BCG) or Alternating BCG and Interferon-α2b Instillations: Prospective Randomised FinnBladder-4 Study Riikka Järvinen, Timo Marttila, Eero Kaasinen, European Urology Urogenital RadiologyUrologySurgical OncologyGenitourinary CancerMedicine	2015	35

Page 1